Where is Thermo Fisher Scientific (TMO) Headed According to Analysts?

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best medical stocks to buy now. Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO) on September 22, setting a price target of $560.00.

Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market

The same day, Eve Burstein from Bernstein also reiterated a Buy rating on the stock and set a price target of $570.00.

Similarly, Barclays upgraded Thermo Fisher Scientific Inc. (NYSE:TMO) to Overweight from Equal Weight on September 11, raising the price target to $550 from $490.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments.

While we acknowledge the potential of TMO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TMO and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.